Deep Learning 4D Glioblastoma Modeling for TTFields Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack the ability to accurately predict the future growth of glioblastoma tumors in patients undergoing tumor treating fields (TTFields) therapy, which is crucial for effective treatment planning.

Innovation Solution

A deep learning model using a convolutional neural network (CNN) with an encoder-decoder architecture and a self-attention mechanism is trained to predict future tumor growth based on MRI scans, incorporating temporal information to generate a 4D representation of tumor spread.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If deep learning models with self-attention mechanisms are used to predict tumor growth, then prediction accuracy and sensitivity are improved, but computational complexity and model architecture complexity increase

Engineering Contradiction:
Improvetumor growth prediction accuracyVSAvoidmodel architecture complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The model processes MRI images through separate encoder and decoder pathways, with the encoder extracting features from input images and the decoder generating prediction maps. This segmentation allows complex prediction tasks to be broken into manageable processing stages, improving accuracy while organizing complexity systematically

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The model transforms 2D MRI slices into 3D volumetric representations by processing multiple slices through the encoder-decoder architecture. This dimensional transformation enables the model to capture spatial relationships across the entire tumor volume, significantly improving prediction accuracy for tumor growth patterns

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Loss of information

If 3D volumetric analysis is performed on MRI data, then tumor spread characterization is improved, but data processing time and computational resources increase

Engineering Contradiction:
Improvetumor spread characterizationVSAvoiddata processing time
Core Design Contradiction:
Loss of informationVSLoss of time

Solution Approach 1:

The encoder performs preliminary feature extraction on all input MRI slices before the decoding stage generates predictions. By pre-processing and extracting essential features from the 3D volumetric data in the encoder stage, the model reduces the computational burden on the decoder, thereby decreasing overall processing time while maintaining comprehensive tumor spread characterization

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The model uses multiple 2D MRI slices as input to reconstruct and characterize the 3D tumor volume. By processing copies of 2D slices through the encoder-decoder architecture, the model efficiently captures 3D tumor characteristics without requiring direct manipulation of large 3D volumetric data, thus reducing processing time

Inventive Principle:
Principle #26Copying

Data Source

PatentUS20250299340A1Deep Learning for Four-Dimensional (4D) Modeling of Glioblastoma Multiforme with Tumor Treating Fields (TTFields) Therapy
Publication Date: 2025.09.25 RGT UNIV OF CALIFORNIA
  • US20250299340A1 patent drawing
  • US20250299340A1 patent drawing
  • US20250299340A1 patent drawing

AI summary

The technology disclosed relates to deep learning for four-dimensional (4D) modeling of glioblastoma multiforme with tumor treating fields (TTFields) therapy. In particular, the technology disclosed relates to a system comprising memory and a neural network processor. The memory stores input image data characterizing a current spatial distribution of glioblastoma multiforme (GBM). The current spatial distribution of the GBM is detected at a precursor examination of a patient receiving tumor treating fields (TTFields) therapy. The neural network processor, is in communication with the memory, and is configured to cause a neural network to process the input image data and, in response, generate output probability data characterizing a future spatial distribution of the GBM at a follow-up examination of the patient receiving the TTFields therapy. The neural network determines the future spatial distribution based in part on a time interval between the precursor examination and the follow-up examination.